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RESEARCH ARTICLE
Outcome and Cost Effectiveness of Ultrasonographically
Guided Surgical Clip Placement for Tumor Localization in
Patients undergoing Neo-adjuvant Chemotherapy for Breast
Cancer
Imrana Masroor1*, Sana Zeeshan2, Shaista Afzal1, Saira Naz Sufian1, Madeeha
Ali2, Shaista Khan2, Khabir Ahmad2
Abstract
Background: To determine the outcome and cost saving by placing ultrasound guided surgical clips for tumor
localization in patients undergoing neo-adjuvant chemotherapy for breast cancer. Materials and Methods: This
retrospective cross sectional analytical study was conducted at the Department of Diagnostic Radiology, Aga Khan
University Hospital, Karachi, Pakistan from January to December 2014. A sample of 25 women fulfilling our
selection criteria was taken. All patients came to our department for ultrasound guided core biopsy of suspicious
breast lesions and clip placement in the index lesion prior to neo-adjuvant chemotherapy. All the selected patients
had biopsy proven breast cancer. Results: The mean age was 45 ± 11.6 years. There were no complications seen
after clip placement in terms of clip migration or hemorrhage. The cost of commercially available markers was
approximately PKR 9,000 (US$ 90) and that of the surgical clip was PKR 900 (US$ 9). The cost of surgical clips
in 25 patients was PKR 22,500 (US$ 225), when compared to the commercially available markers which may
have incurred a cost of PKR 225,000 (US$ 2,250). The total cost saving for 25 patients was PKR 202,500 (US$
2, 025), making it PKR 8100 (US$ 81) per patient. Conclusions: The results of our study show that ultrasound
guided surgical clip placement in index lesions prior to neo-adjuvant therapy is a safe and cost effective method
to identify tumor bed and response to treatment for further management.
Keywords: Breast cancer - neo adjuvant chemotherapy - biopsy - surgical clip marker
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Introduction
Neo-adjuvant chemotherapy (NAC) has revolutionized
the care for patients with operable and inoperable breast
cancers. It has helped to reduce the mortality and improve
the surgical options in terms of making inoperable tumors
excisable and conversion to breast conservation in operable
breasts and early collection of information on the treatment
response and tumor biology of breast cancer (Kaufmann
et al., 2007; Youn et al., 2015). Published studies have
demonstrated a significant clinical response rate of the
primary tumor to neo-adjuvant chemotherapy with success
rates of 80% to 90% (Abdel-Razeq et al., 2011; Lobbes et
al., 2013). At times, a complete clinical, radiological and
pathological response can be achieved after neoadjuvant
therapy, but the results vary widely (6-33%) (Abdel-Razeq
et al., 2011; Lobbes et al., 2013). Although a pathological
complete response is aimed and is associated with good
prognosis, a complete clinical and radiological response
is associated with difficulty for breast surgeon to identify
the exact area for excision corresponding to primary tumor

bed. To avoid this complication, use of radiopaque markers
for the identification of primary tumors after neo-adjuvant
chemotherapy has long been used worldwide and has been
reported as a safe technique for localization of tumor bed
for surgical excision after neo-adjuvant chemotherapy,
particularly with a complete clinical and radiological
response (Oh ., 2007; Kaufmann et al., 2012; Youn et al.,
2015). In a study by (Dash et al., 1999) all the patients
(n=28) underwent clip placement and preoperative
chemotherapy and the study concluded that in 35.7% of
patients, it would have been impossible and in 21.4%
difficult to do wire localizations without clip placement.
They reported that clip placement prior to neo-adjuvant
chemotherapy was valuable in 57% of patients at the time
of needle localization.
In another study (Edeiken et al., 1999), the metallic
markers were the only remaining evidence of original
tumor site in 47% (23 out of 49) of patients. In this
study, all metallic markers were placed under ultrasound
guidance in an assumption that tumor will show complete
or near complete response to neo-adjuvant therapy. This
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study reported that radio opaque marker placement prior
to neo-adjuvant chemotherapy addresses the problem of
preoperative tumor bed localization in patients who are
expected to achieve a complete or near complete response.
In most parts of the world, commercially available
titanium based clips are used for tumor bed localization.
These are placed within the tumor with the help
of radiological assistance such as ultrasound and
mammography (Margolin et al., 2003). Many other
studies conducted in west support the use of radiopaque
clip placement preoperatively for tumor bed localization
before neo-adjuvant chemotherapy. The cost of such clips
varies from between PKR 9,000 to 15,000 (US$ 90 to
150) depending upon make and visibility options. Use of
such radiopaque markers in patients belonging to third
world countries, where the entire treatment expenses are
borne by the patients, can add a substantial cost burden.
Therefore, instead of using the expensive commercially
available markers, we utilized the standard titanium
surgical clips, also known as ligaclips used in various
breast surgeries, as our radiopaque marker. These clips
can be placed easily by a 16G spinal needle, without the
need for commercially available applicator. These clips
are easily available, cost effective (PKR 900, US$ 9),
Magnetic Resonance Imaging (MRI) compatible and
no complications have been reported after their use.
Therefore, the purpose of this study was to review the cost
effectiveness of these surgical clips in terms of tumor bed
localization and any possible complications encountered
during or after clip placement, such as clip migration,
bleeding, infection and pain.

Materials and Methods
It was a retrospective analytical study, conducted at
radiology department of Aga Khan University hospital.
The study duration was from January to December 2014.
Convenience sampling was used. Exemption was granted
from Ethical Review Committee of Aga Khan University
Hospital (ERC # 3594-Rad-ERC-15).
Informed consent
All patients had consented to the placement of ligaclip
within the tumor bed after core biopsy and had signed the
pre-designed hospital consent form. They were counseled
in detail by the primary surgeon as well as the radiologist
before the performance of procedure about the nature of
ligaclip, the method and purpose of placement and the
rare possibility of clip migration as well as associated
complications.
Inclusion criteria
All female patients who had a histopathological
diagnosis of breast cancer on core needle biopsy and were
to undergo neo-adjuvant chemotherapy for reduction in
tumor size were included in the study.
All patients who had their mammograms, ultrasound
and core biopsy and guided clip placement followed by
surgery at our institution were included in the study.
Exclusion criteria
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Patients with incomplete medical records or who had
surgery outside our institution were excluded.
Patients with Stage IV disease and those who showed
progression of disease during or after chemotherapy were
also excluded.
Clip placement technique
All breast biopsies and subsequent clip placements
were performed by radiologist with 5 to 10 year experience
in breast imaging using ultrasound guidance.
All patients initially underwent ultrasound guided
core biopsy of index lesion using a 14G needle with an
automated gun, at least 4 to 5 cores were taken (Figure
1). This was followed by placement of a surgical clip in
the index lesion using a 16G spinal needle. The surgical
clip was closed by an applicator for its easy passage
through the bore of 16G needle. The stylet of 16G spinal
needle was used to advance the clip through the bore of
spinal needle into the center of lesion using ultrasound
guidance. Following successful placement of clips, two
mammographic views were performed in craniocaudal
(Figure 2) and mediolateral projection to ascertain the
correct position of clip within the lesion before discharging
the patient.
Following neo-adjuvant chemotherapy, the
mammograms were repeated to see the response of the
index lesion (Figure 3). In case of complete clinical and
radiological response, if breast conservation was to be
performed, the patient underwent bracketing (Figure 4)
or needle localization of surgical clip (Figure 5) under
mammographic guidance prior to definitive surgery. The
excised specimen was subjected to specimen radiography
to ascertain that the targeted area has been removed
with satisfaction (Figure 6). In case of mastectomy, no
bracketing or needle localization was performed.
All mammogram and ultrasound images were
reviewed by two experienced radiologists with 5 to 10
years of experience in breast imaging. All images of
pre and post ligaclip placement and post neo-adjuvant
chemotherapy were reviewed for correct clip placement,
and possible complications such as clip migration. Medical
record files of all patients were also seen for any possible
complaints after ligaclip insertion on their follow up visit
in breast clinic.
Data analysis
Information was extracted retrospectively from the
hospital’s computerized database and analysis was done
using SPSS version 20. Frequencies and means were
calculated. The percentage of complications was also
recorded. The cost effectiveness was determined by
calculating the cost of ligaclip and commercially available
metallic markers for 25 patients in Pakistani rupees and
US dollars, the cost was also determined for individual
patient. The two figures were subtracted to get the cost
saving.

Results
From January 2014 to December 2014, 350 patients
underwent ultrasound guided core biopsy of breast
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lesions at our institute. Out of these 192 biopsies were
malignant and 158 were benign on histopathology. All
patients with bilateral breast procedures were taken as n=
2. A total of 192 cases had ligaclips placed within their
lesions at the time of core biopsy. Out of 192, only 25
patients fulfilled our selection criteria i.e. biopsy proven
malignant disease of breast with ligaclip in index lesion,
non-metastatic disease, having received NAC followed by
surgery (mastectomy or breast conservation) and available
pre and post neo-adjuvant mammograms with ligaclip
visible in them. Ligaclip in all cases were placed with a
uniform method prior to initiation of NAC. All patients
with benign lesions, incomplete records and progression
of disease during or after chemotherapy were excluded
from this study. The procedures of ligaclip placement as
well as definitive surgery for all the included cases were
performed at our institute only. The mean age of patients
was 45 ± 11.6years. One to 3 ligaclips were placed in a
single lesion. The duration of chemotherapy was from 75 to
200 days. Out of 25 lesions, 15 were in right breast and 10
in the left breast. Maximum number (n=10) of lesions were
in upper outer quadrant. Out of 25 clips 23 were within the
index lesion, two of them were 1 to 2 mm anterior to the
lesion. There was no migration of clips on post procedure
mammograms and subsequent mammograms post
chemotherapy, preoperative mammogram and on surgical

specimen. There were no complications associated with
clip placement such as pain, infection and hemorrhage.
Out of 25 patients, 17 had Invasive Ductal Carcinoma
(IDC) grade III, 5 had IDC II, 2 patients of ductal
carcinoma in situ (DCIS) and 1 patient had metaplastic
carcinoma grade III.
The total cost saving for 25 patients was PKR 202,500
(US$ 2,025). The cost saving for individual patient was
PKR 81,00 (US$ 81).

Figure 1. Ultrasound Guided Core Biopsy Needle
within the Lesion (Arrow)

Figure 3. Craniocaudal View of Right Breast Showing
Reduction in Size of Index Lesion when Compared
with Figure 2 (Arrow)

Figure 2. Craniocaudal View of Right Breast Showing
Ligaclip within Center of Index Lesion (Arrow)

Figure 4. Craniocaudal View of Right Breast Showing
Bracketing of Ligaclip with three Wires (Arrows)

Discussion
Neo-adjuvant chemotherapy (NAC) is now a standard
step in treatment of locally advanced breast cancer when
it is in early stage. NAC leads frequently to better surgical
results by conserving the breast or making inoperable
tumors excisable while lessening complications and
improving cosmetic outcomes.
At our institution, clip placement prior to NAC is a
standard procedure because one cannot predict the tumor
response to NAC. In the past, cases were seen where the
tumors showed complete radiological response both on
mammography and ultrasound making localization of
tumor bed impossible. Therefore, all patients who are to
receive NAC undergo clip placement and are followed up
by mammography and subsequent ultrasound to see tumor
response. Magnetic Resonance Imaging is not performed
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Figure 5. Craniocaudal View of Left Breast Showing
Needle Localization of Ligaclip Prior to Excisional
Biopsy (Black arrow =ligaclip, White arrow =localizing
wire)

Figure 6. Magnified View of Excised Specimen Showing
Ligaclip and Localizing Wire (Black arrow=Ligaclip,
White arrow= localizing wire)
routinely because being a third world country, patient
affordability is a problem as all treatment costs are borne
by the patients because of lack of health care system by
government. The commercially available marker clips
were not available in our institute around 5 years back
when we started this practice. We, along with breast
surgery team decided to use surgical ligature clips as an
alternative to commercially available marker clips. Last
year we were able to import the commercially available
marker clips from abroad. These clips were expensive
so there was a resistance from both the surgeon and
patients regarding their insertion as they increased the
cost of treatment further burdening the patient. When the
patients were given choice of clip types almost all opted
for surgical clip placement. The surgical clips placed had a
cost saving of US$ 81 per patient, and overall cost saving
of US$ 2,025 for 25 patients.
The study was conducted on hypothesis that surgical
clips are cost effective, easy to place and are not associated
with complications of clip migration and hemorrhage.
In our study, all clips were placed under ultrasound
guidance in the same setting when a core biopsy of index
lesion was performed. All clips were inserted using a
16G spinal needle after closing the surgical clip with
an applicator and placing it into the lesion by using the
stylet of the spinal needle. The correct clip placement
was ascertained by ultrasound and doing two views of
mammogram in orthogonal projections. The clip insertion
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using spinal needle was easy and safe as well as cost
effective. In a similar study (Lee at al., 2005; Uematsu
et al., 2007), the authors placed surgical clip by using
automated gun for clip placement, but we used a spinal
needle so we were able to precisely place it in the center
of lesions , because in automated gun technique the
placement is dependent on throw of needle. In another
study (Youn et al., 2015), a semi-automated gun was
used but in their study, core needle biopsy and clip
insertion were done in two different sittings, as most of
their patients had their core needle biopsy performed
from another hospital. In contrast, we performed core
needle biopsy of index lesion and any suspicious
axillary lymph nodes along with clip placement in index
lesion during the same visit for all patients as it is more
convenient and a cost and time effective methodology.
Clip migration can be a limitation of clip insertion
especially in fatty breasts but the clip is inserted in the
center of index lesion, thus minimizing clip migration
due to higher resistance (Margolin et al., 2003). There
was no clip migration at the time of clip insertion, post
chemotherapy and in surgical specimen on mammography
in all of our patients. The clips allowed easy identification
of cancer on mammography and helped surgeons in
explaining the findings to patients. Many studies in
the past have concluded that placement of radiopaque
markers are beneficial for tumor localization as well as
for the assessment of tumor response to NAC, without
disturbing radiologic evaluation of main lesion (Dash et
al., 1999; Baron et al., 2000; Oh et al., 2007; Genson
et al., 2007). We were able to evaluate tumor response
post NAC and localize it with the help of mammography
as a metallic density and on ultrasound as a small linear
echogenic structure with or without shadowing. We did
not perform MRI on our patients due to cost constraints.
MRI is a better modality for assessing tumor response to
chemotherapy, this has been reported in several studies
but the metallic clip produces artifacts in form of signal
void depending upon magnetic susceptibility, clip quality,
size, shape, orientation, position and parameters used for
MRI examination (Genson et al., 2007).
There are a few limitations of this study. The sample
size was 25, however with 25 patients in this study we
still can conclude that there was significant cost saving
per patient if we consider cost constraints for a self-paying
patient in a third world country. The results for clip
migration and complications cannot be generalized due
to small sample; studies with larger sample size should be
conducted to generalize the results on larger population
groups. Another limitation is non-conductance of MR
examination to see tumor response in our patients again
because of cost constraints on patients. However we have
evaluated tumor response to NAC by mammography
and ultrasound and have obtained almost similar results
to studies using mammography, ultrasound and MRI.
However, in a study by (Genson et al., 2007), it is reported
that artifacts caused by tissue marker clips can limit the
sensitivity of MRI for detection and follow up of breast
cancer.
In conclusion, we concluded from this study that
ligaclip placement in patients with breast cancer
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undergoing NAC is a cost effective method for following
response to NAC and is helpful in further surgical
management post NAC. It is not associated with clip
migration or significant complications related to clip
placement but larger studies are needed to generalize
our results.
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